OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
Not yet recruiting · NCT07221799 · Registry updated 2025-10-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis | CNS demyelinating autoimmune disease, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Not yet recruiting | Phase 1 | 2025-10-28 | NCT07221799 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Maryland School of Medicine | Baltimore | United States | 30 |